1. International Center for Infectiology Research, Team Enveloped Viruses, Vectors and Innate Responses, INSERM, U1111, Université Claude Bernard Lyon 1, Centre National de la Recherche Scientifique, Unité Mixte de Recherche (UMR) 5308, Ecole Normale Supérieure de Lyon, Lyon, France;
2. LabEx Ecofect, Université de Lyon, Lyon, France;
3. Laboratory of Viral Vectors and Gene Therapy, Institute of Basic Sciences and Experimental Medicine, Italian Hospital School of Medicine Argentina, Buenos Aires, Argentina;
4. Division of Hematopoietic Innovative Therapies, Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas, Madrid, Spain;
5. Advanced Therapies Unit, Instituto de Investigación Sanitaria Fundación Jiménez Díaz, Madrid, Spain;
6. Centro de Investigación Biomédica en Red de Enfermedades Raras, Madrid, Spain;
7. Laboratory for Viral Vector Technology & Gene Therapy, Department of Pharmaceutical and Pharmacological Sciences, Faculty of Medicine, Katholieke Universiteit Leuven, Leuven, Belgium;
8. Institut de Génétique Moléculaire de Montpellier, Centre National de la Recherche Scientifique UMR5535, Universités de Montpellier 1 et 2, Montpellier, France;
9. Laboratory of Excellence GR-Ex, Paris, France;
10. Institute for Medical Informatics and Biometry, Faculty of Medicine Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany;
11. Department of Pediatric Hematology and Oncology, Division of Pediatric Stem Cell Transplantation and Immunology, Research Institute Children’s Cancer Center Hamburg, Hamburg, Germany; and
12. INSERM, U1065, Centre Méditerranéen de Médecine Moléculaire, Équipe “Contrôle Métabolique des Morts Cellulaires,” Nice, France